Welcome to the Psychiatry Consortium
Accelerating innovative drug discovery
The Psychiatry Consortium is a strategic collaboration of leading medical research charities and pharmaceutical companies focusing on the challenge of identifying and validating novel drug targets to address the unmet therapeutic needs of the people living with mental health conditions.
Our Mission
The scale and impact of mental illness across society is huge. One in ten children, and one in four adults (approx. 15 million people) experience mental illness each year, affecting their wellbeing, relationships, and potential ability to work.
Our Approach
We bring together key Research and Development players in a focussed effort to identify and validate novel drug targets to address the unmet therapeutic needs of those living with mental illness, including psychiatric symptoms associated with dementia.
